Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicentre study

European Journal of Cancer

Volumn 51, Issue 8, 2015, Pages 925-934

  Tougeron, D ^a   Sickersen, G ^a   Mouillet, G ^b   Zaanan, A ^c   Trouilloud, I ^d   Coriat, R ^e   Aparicio, T ^f   Des Guetz, G ^f   Lecaille, C ^g   Artru, P ^h   Cauchin, E ⁱ   Sefrioui, D ^j   Boussaha, T ^k   Ferru, A ^a   Matysiak Budnik, T ⁱ   Silvain, C ^a   Karayan Tapon, L ^a   Pages J C ^l   Vernerey, D ^b   Bonnetain, F ^b   Michel, P ^j   Taieb J ^c   Lecomte, T ^l   more..

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d HÔPITAL AMBROISE PARÉ   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f AVICENNE HOSPITAL   (France)

^g Clinic Bordeaux Nord   (France)

^h Private Hospital Jean Mermoz   (France)

ⁱ NANTES UNIVERSITY HOSPITAL   (France)

^j ROUEN UNIVERSITY HOSPITAL   (France)

^k HÔPITAL SAINT ANTOINE   (France)

^l UNIVERSITÉ DE TOURS   (France)

more..

Author keywords

Colorectal cancer; Microsatellite instability; Prognosis; Surgery; Vascular emboli

Indexed keywords

B RAF KINASE; FLUOROPYRIMIDINE; GENOMIC DNA; OXALIPLATIN; TUMOR MARKER;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA EXTRACTION; FEMALE; FOLLOW UP; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE OBSTRUCTION; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MULTICENTER STUDY (TOPIC); OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE RISK; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR RECURRENCE; ABDOMINAL SURGERY; ADJUVANT CHEMOTHERAPY; CLINICAL TRIAL; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; GENETICS; MIDDLE AGED; MULTICENTER STUDY; PROGNOSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84928952845     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.03.011     Document Type: Article

References (24)

1. C.M. Ribic, D.J. Sargent, and M.J. Moore Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med 349 2003 247 257
2. F.A. Sinicrope, N.R. Foster, and S.N. Thibodeau DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-Fluorouracil-based adjuvant therapy J Natl Cancer Inst 103 2011 863 875
3. S. Popat, R. Hubner, and R.S. Houlston Systematic review of microsatellite instability and colorectal cancer prognosis J Clin Oncol 23 2005 609 618
4. D.J. Sargent, S. Marsoni, and G. Monges Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer J Clin Oncol 28 2010 3219 3226
5. R. Jover, P. Zapater, and A. Castells The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status Eur J Cancer 45 2009 365 373
6. D. Sargent, Q. Shi, and G. Yothers Prognostic impact of deficient mismatch repair (dMMR) in 7,803 stage II/III colon cancer (CC) patients (pts): a pooled individual pt data analysis of 17 adjuvant trials in the ACCENT database J Clin Oncol 32 2014 [abstr 3507]
7. A. Zaanan, J.F. Flejou, and J.F. Emile Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy Clin Cancer Res 17 2011 7470 7478
8. P. Gavin, L.H. Colangelo, and D. Fumagalli Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value Clin Cancer Res 18 2012 6531 6541
9. F.A. Sinicrope, M.R. Mahoney, and T.C. Smyrk Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy J Clin Oncol 31 2013 3664 3672
10. J. Fléjou, T. André, and B. Chibaudel Effect of adding oxaliplatin to adjuvant 5-fluorouracil/leucovorin (5FU/LV) in patients with defective mismatch repair (dMMR) colon cancer stage II and III included in the MOSIAC study J Clin Oncol 31 2013 [abstr 3524]
11. T. Andre, C. Boni, and M. Navarro Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial J Clin Oncol 27 2009 3109 3116
12. K. Baker, I. Zlobec, L. Tornillo, L. Terracciano, J.R. Jass, and A. Lugli Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: a potential role for dysregulation of the transforming growth factor-beta pathway Eur J Cancer 43 2007 624 631
13. H.H. Yoon, D. Tougeron, and Q. Shi KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance) Clin Cancer Res 20 2014 3033 3043
14. C.R. Boland, S.N. Thibodeau, and S.R. Hamilton A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res 58 1998 5248 5257
15. N. Suraweera, A. Duval, and M. Reperant Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR Gastroenterology 123 2002 1804 1811
16. R. Gryfe, H. Kim, and E.T. Hsieh Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer N Engl J Med 342 2000 69 77
17. Y. Parc, S. Gueroult, and N. Mourra Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer Gut 53 2004 371 375
18. D. Tougeron, P. Maby, and N. Elie Regulatory T lymphocytes are associated with less aggressive histologic features in microsatellite-unstable colorectal cancers PloS One 8 2013 e61001
19. A.I. Phipps, D.D. Buchanan, and K.W. Makar BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics Cancer Epidemiol Biomarkers Prev 21 2012 1792 1798
20. P. Lochhead, A. Kuchiba, and Y. Imamura Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication J Natl Cancer Inst 105 2013 1151 1156
21. A.D. Roth, M. Delorenzi, and S. Tejpar Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer J Natl Cancer Inst 104 2012 1635 1646
22. F.A. Sinicrope, and Q. Shi Combining molecular markers with the tnm staging system to improve prognostication in stage II and III colon cancer: are we ready yet? J Natl Cancer Inst 104 2012 1616 1618
23. D.J. Sargent, H.S. Wieand, and D.G. Haller Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials J Clin Oncol 23 2005 8664 8670
24. K. Inamura, M. Yamauchi, and R. Nishihara Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis J Natl Cancer Inst 106 2014